Reverse iontophoresis for non-invasive transdermal monitoring

Physiological Measurement

Volumn 25, Issue 3, 2004, Pages

  Leboulanger, Benoît ^a,b   Guy, Richard H ^a,b   Delgado Charro, M Begoña ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Parc d'Affaires International   (France)

Author keywords

Electromigration; Electroosmosis; Glucose monitoring; Iontophoresis; Therapeutic drug monitoring

Indexed keywords

CONTROLLED DRUG DELIVERY; ELECTROMIGRATION; ELECTROOSMOSIS; ELECTROTHERAPEUTICS; GLUCOSE; TARGETED DRUG DELIVERY;

GLUCOSE MONITORING; INTERNAL STANDARDS; NEUTRAL COMPOUNDS; REVERSE IONTOPHORESIS; SKIN SURFACES; THERAPEUTIC DRUG MONITORING; TOTAL CHARGE; TRANSDERMAL; TRANSDERMAL DRUG DELIVERY; TRANSDERMAL IONTOPHORESIS;

ELECTROPHORESIS;

GLUCOSE;

ANALYTIC METHOD; BLOOD GLUCOSE MONITORING; CALIBRATION; DEVICE; DRUG DELIVERY SYSTEM; DRUG ISOLATION; DRUG MONITORING; ELECTRIC CURRENT; ELECTRIC POTENTIAL; ELECTRON TRANSPORT; ELECTROOSMOSIS; HUMAN; IONTOPHORESIS; MEASUREMENT; PARAMETER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN ELECTRODE; SKIN SURFACE; STANDARD; TECHNIQUE; TRANSDERMAL DRUG ADMINISTRATION;

EID: 3142547033     PISSN: 09673334     EISSN: None     Source Type: Journal    
DOI: 10.1088/0967-3334/25/3/R01     Document Type: Review

References (46)

1. Benjamin F B, Kempen R, Mulder A G and Ivy A C 1954 Sodium-potassium ratio of human skin as obtained by reverse iontophoresis J. Appl. Physiol. 6 401-7
2. Burnette R R 1989 Iontophoresis TransdermalDrug Delivery ed J Hadgraft and R H Guy (New York: Marcel Dekker) pp 247-91
3. Burnette R R and Ongpipattanakul B 1987 Characterization of the permselective properties of excised human skin during iontophoresis J. Pharm. Sci. 76 765-73
4. Cullander C, Rao G and Guy R H 1993 Why silver/silver chloride? Criteria for iontophoresis electrodes Proc. 3rd Int. Prediction of Percutaneous Penetration Conf. (La Grande Motte, France) ed K R Brain, V J James and K A Watters pp 381-90
5. Cygnus, Inc. 2002 GlucoWatch: Automatic Glucose Biographer http://www.glucowatch.com
6. Degim I T, Ilbasmis S, Dundaroz R and Oguz Y 2003 Reverse iontophoresis: a non-invasive technique for measuring blood urea level Pediatr. Nephrol. 18 1032-7
7. Delgado-Charro M B and Guy R H 1994 Characterization of convective solvent flow during iontophoresis Pharm. Res. 11 929-35
8. Delgado-Charro M B and Guy R H 2001 Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring S T P Pharm. Sci. 11 403-14
9. Delgado-Charro M B and Guy R H 2003 Transdermal reverse iontophoresis of valproate: a non-invasive method for therapeutic drug monitoring Pharm. Res. 20 1508-13
10. Eastman R C et al 2002 Use of the GlucoWatch® biographer in children and adolescents with diabetes Pediatr. Diabetes 3 127-34
11. Garg S K, Potts R O, Ackerman N R, Fermi S J, Tamada J A and Chase H P 1999 Correlation of fingerstick blood glucose measurements with GlucoWatch Biographer glucose results in young subjects with type 1 diabetes Diabetes Care 22 1708-14
12. Glikfeld P, Hinz R S and Guy R H 1989 Noninvasive sampling of biological fluids by iontophoresis Pharm. Res. 6 988-90
13. Guy R H, Delgado-Charro M B and Kalia Y N 2001 Iontophoretic transport across the skin Skin Pharmacol. Appl. Skin Physiol. 14 35-40
14. Leboulanger B, Aubry J-M, Bondolfi G, Guy R H and Delgado-Charro M B 2003a Reverse iontophoretic monitoring of lithium in vivo Proc. 8th Int. Cong. of Therapeutic Drug Monitoring & Clinical Toxicology, Ther. Drug Monit. 25 499
15. Leboulanger B, Fathi M, Guy R H and Delgado-Charro M B 2003b Therapeutic drug monitoring by reverse iontophoresis Proc. 30th Controlled Release Society Annual Meeting
16. Leboulanger B, Guy R H and Delgado-Charro M B 2003c Reverse iontophoretic monitoring of free phenytoin Proc. 8th Int. Cong. of Therapeutic Drug Monitoring & Clinical Toxicology, Ther. Drug Monit. 25 499
17. Ledger P W 1992 Skin biological issues in electrically enhanced transdermal delivery Adv. Drug Deliv. Rev. 9 289-307
18. Leduc S 1900 Introduction of medicinal substances into the depth of tissues by electric current Ann. Electrobiol. 3 545-60
19. Luzardo-Alvarez A, Delgado-Charro M B and Blanco-Mendez J 2001 Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation Pharm. Res. 18 1714-20
20. Merino V, Kalia Y N and Guy R H 1997 Transdermal therapy and diagnosis by iontophoresis Trends Biotechnol. 15 288-90
21. Merino V, Lopez A, Hochstrasser D and Guy R H 1999 Noninvasive sampling of phenylalanine by reverse iontophoresis J. Control Release 61 65-9
22. Mize N K, Buttery M, Daddona P, Morales C and Cormier M 1997 Reverse iontophoresis: monitoring prostaglandin E2 associated with cutaneous inflammation in vivo Exp. Dermatol. 6 298-302
23. Numajiri S, Sugibayashi K and Morimoto Y 1993 Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard J. Pharm. Biomed. Anal. 11 903-9
24. Padmanabhan R V, Phipps J B, Lattin G A and Sawchuk R J 1990 In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone J. Control Release 11 123-35
25. Phipps J B and Gyory J R 1992 Transdermal ion migration Adv. Drug Deliv. Rev. 9 137-76
26. Phipps J B, Padmanabhan R V and Lattin G A 1989 Iontophoretic delivery of model inorganic and drug ions J. Pharm. Sci. 78 365-9
27. Pikal M J 1990 Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis Pharm. Res. 7 118-26
28. Pikal M J 1992 The role of electroosmotic flow in transdermal iontophoresis Adv. Drug Deliv. Rev. 9 201-37
29. Pikal M J and Shah S 1990 Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes Pharm. Res. 7 222-31
30. Pitzer K R, Desai S, Dunn T, Edelman S, Jayalakshmi Y, Kennedy J, Tamada J A and Potts R O 2001 Detection of hypoglycemia with the Glucowatch biographer Diabetes Care 24 881-5
31. Potts R O, Tamada J A and Tierney M J 2002 Glucose monitoring by reverse iontophoresis Diabetes Metab. Res. Rev. 18 S49-53
32. Rao G, Glikfeld P and Guy R H 1993 Reverse iontophoresis: development of a non invasive approach for glucose monitoring Pharm. Res. 10 1751-5
33. Rao G, Guy R H, Glikfeld P, LaCourse W R, Leung L, Tamada J, Potts R O and Azimi N 1995 Reverse iontophoresis: non invasive glucose monitoring in vivo in humans Pharm. Res. 12 1869-73
34. Sage B H and Riviere J E 1992 Model systems in iontophoresis-transport efficacy Adv. Drug Deliv. Rev. 9 265-87
35. Santi P and Guy R H 1996a Reverse iontophoresis-parameters determining electroosmotic flow: I. pH and ionic strength J. Control Release 38 159-65
36. Santi P and Guy R H 1996b Reverse iontophoresis-parameters determining electro-osmotic flow: II. Electrode chamber formulation J. Control Release 42 29-36
37. Scott E R, Phipps J B, Gyory J R and Padmanabhan R V 2000 Electrotransport systems for transdermal delivery: a practical implementation of iontophoresis Handbook of Pharmaceutical Controlled Release Technology ed D L Wise (New York: Marcel Dekker) pp 617-59
38. Sekkat N, Naik A, Kalia Y N, Glikfeld P and Guy R H 2002 Reverse iontophoretic monitoring in premature neonates: feasibility and potential J. Control Release 81 83-9
39. Sieg A, Guy R H and Delgado-Charro M B 2003 Reverse iontophoresis for non-invasive glucose monitoring: the internal standard concept J. Pharm. Sci. 92 2295-302
40. Tamada J A, Bohannon N J V and Potts R O 1995 Measurement of glucose in diabetic subjects using noninvasive transdermal extraction Nat. Med. 1 1198-201
41. Tamada J A, Garg S, Jovanovic L, Pitzer K R, Fermi S, Potts R O and Cygnus Research Team 1999 Noninvasive glucose monitoring. Comprehensive clinical results JAMA 282 1839-44
42. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus N. Eng. J. Med. 329 977-86
43. Tierney M J, Jayalakshmi Y, Parris N A, Reidy M P, Uhegbu C and Vijayakumar P 1999 Design of a biosensor for continual transdermal glucose monitoring Clin. Chem. 45 1681-83
44. Tierney M J, Kim H L, Burns M D, Tamada J A and Potts R O 2000a Electroanalysis of glucose in transcutaneously extracted samples Electroanalysis 12 666-71
45. Tierney M J, Tamada J A, Potts R O, Eastman R C, Pitzer K, Ackerman N R and Fermi S J 2000b The GlucoWatch® biographer: a frequent automatic and noninvasive glucose monitor Ann. Med. 32 632-41
46. Tierney M J, Tamada J A, Potts R O, Jovanovic L, Garg S and Cygnus Research Team 2001 Clinical evaluation of the GlucoWatch® biographer: a continual, non-invasive glucose monitor for patients with diabetes Biosens. Bioelectron. 16 621-9